Risk of major bleeding and the standard doses of dabigatran

Eur J Intern Med. 2014 Jul;25(6):e73-5. doi: 10.1016/j.ejim.2014.02.005. Epub 2014 Mar 11.
No abstract available

Keywords: Anticoagulants; Atrial fibrillation; Meta-analysis; Review; Venous thromboembolism.

Publication types

  • Letter
  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antithrombins / adverse effects*
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / drug therapy*
  • Benzimidazoles / adverse effects*
  • Dabigatran
  • Hemorrhage / chemically induced*
  • Humans
  • Randomized Controlled Trials as Topic
  • Risk
  • Stroke / etiology
  • Stroke / prevention & control*
  • Venous Thromboembolism / prevention & control*
  • beta-Alanine / adverse effects
  • beta-Alanine / analogs & derivatives*

Substances

  • Antithrombins
  • Benzimidazoles
  • beta-Alanine
  • Dabigatran